U.S. Recommends Pausing Use Of Johnson & Johnson Vaccine Over Blood Clot Concerns

Content Curator
The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention have recommended a pause in the use of the Johnson & Johnson COVID-19 vaccine, shown here in a hospital in Denver.

In a statement on Tuesday, U.S. authorities said they are "reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine."

(Image credit: David Zalubowski/AP)